<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00827853</url>
  </required_header>
  <id_info>
    <org_study_id>BOSTON SCI R&amp;E 9-21-07#2</org_study_id>
    <nct_id>NCT00827853</nct_id>
  </id_info>
  <brief_title>Study Comparing Two Methods of Expanding Stents Placed in Legs of Diabetics With Peripheral Vascular Disease</brief_title>
  <acronym>COBRA</acronym>
  <official_title>PolarCath® Cryoplasty Versus Conventional Balloon Post-dilation of Nitinol Stents for Peripheral Vascular Interventions (COBRA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>North Texas Veterans Healthcare System</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>North Texas Veterans Healthcare System</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Despite recent advances in stent technology and its widespread application in the treatment
      of peripheral vascular disease (PVD), incidences of partial or complete blockage of stent
      lumen (in-stent restenosis) due to in growth of cells (neo-intimal proliferation) is
      unacceptably high.

      In diabetics with long superficial femoral artery (SFA) lesions, in-stent restenosis rates
      are higher than in non-diabetics. Consequently interventional techniques that curtail
      in-stent restenosis have to be explored. Cryoplasty is a stent expansion method in which a
      balloon is expanded using pressurized nitrous oxide gas. As the nitrous oxide expands in the
      balloon it cools the surroundings to about -10 degrees C. This induces programed death
      (apoptosis) of the smooth muscle cells in arterial wall.

      The investigators hypothesize that Cryoplasty, by inducing an apoptotic smooth muscle cell
      response, when applied to post-dilation of nitinol self-expanding stents in the Superficial
      Femoral Artery (SFA) of diabetics, would lead to decreased in-stent restenosis due to
      decreased neointimal proliferation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The pre-recruitment process would identify diabetics who have life-style limiting
      claudication in their legs. Based on the physicians decision such patients may have to
      undergo a peripheral vascular intervention of the SFA, with placement of self-expanding
      nitinol stents. If such a decision is made, the patient will be randomized to either
      cryoplasty balloon post-dilation of the stent or to conventional angioplasty balloon
      post-dilation after obtaining informed consent. At one year, in segment (stent + 10 mm beyond
      its proximal and distal edges) peak systolic velocity by duplex ultrasound will be measured
      in all subjects to assess the rate of binary restenosis defined as a &gt; or = 2.5 times
      increase in peak systolic velocity (primary endpoint). A 6 month resting ankle brachial
      index, and binary restenosis may be assessed as a secondary endpoint of the study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2008</start_date>
  <completion_date type="Actual">February 2012</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of binary restenosis as determined by duplex ultrasound.</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Resting ankle-brachial index</measure>
    <time_frame>6 months and 1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>PERIPHERAL VASCULAR DISEASE</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Conventional angioplasty balloon post-dilation of nitinol self expanding stents</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cryoplasty balloon post-dilation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional angioplasty balloon</intervention_name>
    <description>Post-dilation of clinically indicated nitinol self-expanding stents in the SFA using conventional angioplasty balloon</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>cryoplasty balloon</intervention_name>
    <description>Post-dilation of clinically indicated nitinol self-expanding stents in the SFA using cryoplasty balloon</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diabetics, insulin or non-insulin dependent above 21 years of age

          -  Able to provide an informed consent

          -  Life expectancy &gt; 1 year

          -  Presenting with with moderate claudication (Rutherford stage 2), severe intermittent
             claudication (Rutherford stage 3), chronic critical limb ischemia with pain while the
             patient was at rest(Rutherford stage 4), or chronic critical limb ischemia with
             ischemic ulcers/gangrene(Rutherford stage 5/6)

          -  Placement of &gt; 5 mm in diameter self-expanding Nitinol stent in the SFA, with at least
             1 vessel infra-popliteal runoff

          -  Placement of &gt; 60 mm in length self-expanding Nitinol stent in the SFA, with at least
             1 vessel infra-popliteal runoff

        Exclusion Criteria:

          -  Serum creatinine of &gt;= 2.0 mg/dl

          -  Presence of iodinated contrast allergy

          -  Presence of allergy to Aspirin and Plavix

          -  Pregnancy

          -  Relative or absolute contraindication for anticoagulation

          -  History of allergy to Angiomax and unfractionated heparin or heparin induced
             thrombocytopenia (HIT)

          -  White blood count &lt; 3000; platelet count &lt; 100000, and baseline hemoglobin &lt; 10 g/dl

          -  Absence of brisk at least 1 vessel infra-popliteal runoff to the foot

          -  Left ventricular ejection fraction &lt; 25%

          -  Relative or absolute contraindication for anticoagulation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Subhash Banerjee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA North Texas Healthcare Systen, Dallas, TX</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Emmanouil S Brilakis, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>VA North Texas Healtcare System, Dallas, TX</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tony S Das, MD</last_name>
    <role>Study Director</role>
    <affiliation>Texas Health Resources</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Midwest Cardiovascular Research Foundation</name>
      <address>
        <city>Davenport</city>
        <state>Iowa</state>
        <zip>52803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dallas Veterans Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dallas Presbyterian Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75231</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Minar E, Pokrajac B, Maca T, Ahmadi R, Fellner C, Mittlböck M, Seitz W, Wolfram R, Pötter R. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty : results of a prospective randomized study. Circulation. 2000 Nov 28;102(22):2694-9.</citation>
    <PMID>11094034</PMID>
  </reference>
  <reference>
    <citation>Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, Schlager O, Cejna M, Lammer J, Minar E. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006 May 4;354(18):1879-88.</citation>
    <PMID>16672699</PMID>
  </reference>
  <reference>
    <citation>Cejna M, Thurnher S, Illiasch H, Horvath W, Waldenberger P, Hornik K, Lammer J. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. J Vasc Interv Radiol. 2001 Jan;12(1):23-31.</citation>
    <PMID>11200349</PMID>
  </reference>
  <reference>
    <citation>Becquemin JP, Favre JP, Marzelle J, Nemoz C, Corsin C, Leizorovicz A. Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomized study. J Vasc Surg. 2003 Mar;37(3):487-94.</citation>
    <PMID>12618680</PMID>
  </reference>
  <reference>
    <citation>Sabeti S, Mlekusch W, Amighi J, Minar E, Schillinger M. Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries. J Endovasc Ther. 2005 Feb;12(1):6-12.</citation>
    <PMID>15683273</PMID>
  </reference>
  <reference>
    <citation>Johnston KW. Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. Radiology. 1992 Jun;183(3):767-71.</citation>
    <PMID>1294068</PMID>
  </reference>
  <reference>
    <citation>Zdanowski Z, Albrechtsson U, Lundin A, Jonung T, Ribbe E, Thörne J, Norgren L. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study. Int Angiol. 1999 Dec;18(4):251-5.</citation>
    <PMID>10811511</PMID>
  </reference>
  <reference>
    <citation>Sabeti S, Schillinger M, Amighi J, Sherif C, Mlekusch W, Ahmadi R, Minar E. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis. Radiology. 2004 Aug;232(2):516-21.</citation>
    <PMID>15286322</PMID>
  </reference>
  <reference>
    <citation>Duda SH, Pusich B, Richter G, Landwehr P, Oliva VL, Tielbeek A, Wiesinger B, Hak JB, Tielemans H, Ziemer G, Cristea E, Lansky A, Bérégi JP. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation. 2002 Sep 17;106(12):1505-9.</citation>
    <PMID>12234956</PMID>
  </reference>
  <reference>
    <citation>Schillinger M, Exner M, Mlekusch W, Haumer M, Sabeti S, Ahmadi R, Schwarzinger I, Wagner O, Minar E. Restenosis after femoropopliteal PTA and elective stent implantation: predictive value of monocyte counts. J Endovasc Ther. 2003 Jun;10(3):557-65.</citation>
    <PMID>12932168</PMID>
  </reference>
  <reference>
    <citation>Yiu WK, Cheng SW, Sumpio BE. Vascular smooth muscle cell apoptosis induced by &quot;supercooling&quot; and rewarming. J Vasc Interv Radiol. 2006 Dec;17(12):1971-7.</citation>
    <PMID>17185696</PMID>
  </reference>
  <reference>
    <citation>Venkatasubramanian RT, Grassl ED, Barocas VH, Lafontaine D, Bischof JC. Effects of freezing and cryopreservation on the mechanical properties of arteries. Ann Biomed Eng. 2006 May;34(5):823-32. Epub 2006 Apr 18.</citation>
    <PMID>16619131</PMID>
  </reference>
  <reference>
    <citation>Grassl ED, Bischof JC. In vitro model systems for evaluation of smooth muscle cell response to cryoplasty. Cryobiology. 2005 Apr;50(2):162-73.</citation>
    <PMID>15843006</PMID>
  </reference>
  <reference>
    <citation>Laird J, Jaff MR, Biamino G, McNamara T, Scheinert D, Zetterlund P, Moen E, Joye JD. Cryoplasty for the treatment of femoropopliteal arterial disease: results of a prospective, multicenter registry. J Vasc Interv Radiol. 2005 Aug;16(8):1067-73.</citation>
    <PMID>16105918</PMID>
  </reference>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 22, 2009</study_first_submitted>
  <study_first_submitted_qc>January 22, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 23, 2009</study_first_posted>
  <last_update_submitted>November 1, 2013</last_update_submitted>
  <last_update_submitted_qc>November 1, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 4, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>North Texas Veterans Healthcare System</investigator_affiliation>
    <investigator_full_name>Subhash Banerjee</investigator_full_name>
    <investigator_title>Chief of Cardiology</investigator_title>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>Peripheral Vascular Disease (PVD)</keyword>
  <keyword>Superficial Femoral Artery (SFA)</keyword>
  <keyword>Cryoplasty</keyword>
  <keyword>Restenosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

